Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group.
about
Phosphodiesterase III inhibitors for heart failureDo medical house officers value the health of veterans differently from the health of non-veterans?Quality-of-Life measures for cardiac surgery practice and research: a review and primerA Couples' Based Self-Management Program for Heart Failure: Results of a Feasibility StudyDilated Cardiomyopathy: Phosphorus 31 MR Spectroscopy at 7 T.Effect of renal function on prognosis in chronic heart failure.Treating anemia in older adults with heart failure with a preserved ejection fraction with epoetin alfa: single-blind randomized clinical trial of safety and efficacy.Reliability and construct validity of PROMISĀ® measures for patients with heart failure who undergo heart transplant.The impact of chronic heart failure on health-related quality of life data acquired in the baseline phase of the CARE-HF study.Explanation of the variance in quality of life and activity capacity of patients with heart failure by laboratory data.Nutrition intervention to decrease symptoms in patients with advanced heart failure.Dose-dependent relationship of physical and depressive symptoms with health-related quality of life in patients with heart failure.Health-related quality of life. A guide for the health professional.Evaluation of item candidates: the PROMIS qualitative item review.Patients' self-assessed functional status in heart failure by New York Heart Association class: a prognostic predictor of hospitalizations, quality of life and death.Cohort profile: Greifswald approach to individualized medicine (GANI_MED)A classification scheme for outcome indicators.Social status, health-related quality of life, and event-free survival in patients with heart failure.Effects of multidisciplinary Internet-based program on management of heart failure.Quality of life and functional status in patients surviving 12 months after left ventricular assist device implantation.The effect of beta-blockers on health-related quality of life in patients with heart failure.Assessing technological change in cardiothoracic surgery.Link between change in cognition and left ventricular function following cardiac resynchronization therapy.Effect of valsartan added to background ACE inhibitor therapy in patients with heart failure: results from Val-HeFT.Correlates of quality of life in rural patients with heart failure.Change in health status in long-term conditions over a one year period: a cohort survey using patient-reported outcome measures.Trial of a family-based education program for heart failure patients in rural Thailand.The impact of anxiety, depression, and suicidality on quality of life and functional status of patients with congestive heart failure and hypertension: an observational cross-sectional study.Who Signs Up for and Engages in a Peer Support Heart Failure Self-management InterventionESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with theIdentifying patients hospitalized with heart failure at risk for unfavorable future quality of life.British randomised controlled trial of AV and VV optimization ("BRAVO") study: rationale, design, and endpoints.Comparison of cardiac and pulmonary-specific quality-of-life measures in pulmonary arterial hypertensionQuality of life impacts on 16-year survival of an older ethnically diverse cohort.Factors associated with perceived control and the relationship to quality of life in patients with heart failure.Psychometric properties of the Symptom Status Questionnaire-Heart Failure.Correlation between B-Type Natriuretic Peptide and Functional/Cognitive Parameters in Discharged Congestive Heart Failure Patients.Psychosocial factors and their association with clinical outcomes in patients with heart failure: why clinicians do not seem to care.Selection of endpoints for heart failure clinical trials.Effect of a medication-taking behavior feedback theory-based intervention on outcomes in patients with heart failure.
P2860
Q24244978-F282CEA3-F8F8-4DA6-A264-E8D7F2B8F813Q24797333-CF7B0E4C-D001-46F5-983F-88F2CEA4DDE0Q27015844-2B24B92B-4430-4CCC-8A80-D2411849E940Q27303685-B6B7220D-E1C4-4246-A0D4-E2D0033F5D2FQ30355877-9A0C7F1C-22AD-4F06-BE9A-A7C502BB22DCQ30361766-BA58AFDB-9588-46D9-BF74-FB12BDFFBB5FQ30442221-FDEB059B-283F-431D-B74B-2C481B0F38CDQ30666832-00686378-07FB-4AEE-B480-77C2AFFA0845Q30982366-236781DB-023D-4BD1-88AE-2BEBA2042E84Q33516689-BE915B14-0492-4C93-8793-FA69CEBEB6A0Q33572474-CACFD223-7E1F-4144-9414-6758CAEB8CE1Q33574074-A808FEA3-A21C-424B-8D1F-4182131D01D7Q33583290-3F3700A6-96C5-4EB9-9D3F-A8D26A921D1AQ33607403-F3882CA1-BFE9-4C35-84DA-76C81A5D2135Q33635008-BB8E833D-1B16-47E0-A011-E3845D86EA4AQ33694054-F630B3F7-5DC4-4A9D-9F3A-975FE49CB06BQ33812872-426345D2-4A44-4767-ADFE-2619F23B6EDAQ33855082-8329B8E6-2AE1-4257-9A31-BC9A5B496598Q33873846-C9223170-5525-4BD5-B1C4-6BC38D74E191Q33920259-9115822C-6394-449C-AE72-56631C293399Q33942862-F1390977-051A-4ABE-A98B-8B4F036067CDQ34111912-C756DF19-387C-4F37-9DAA-23F1C74CEA09Q34297778-DF89BAD6-5039-4803-9BE0-CCFF1DC8AE02Q34369863-BBD345D8-A456-4A51-9D59-05A8307D3A07Q34559820-E41DD955-CCA2-4E01-B791-57B82C393EB1Q34571279-73AA2EB3-5F71-404C-A1BB-380F4CC8A2B9Q34695096-31145D4C-C826-470F-ACC4-E7EA74BCC062Q34743039-088545C7-FCEC-4A37-A004-6A89D76CD55BQ34772635-0076C6EF-9D7D-4217-BF70-7E524D358ED3Q34830023-801E077E-D176-4D79-A181-FBD8A1D78C42Q35137197-D74400F6-BB39-4BDF-A79B-6D71D4B1D1C4Q35137989-2AD62B51-4436-4E18-9C51-691AAE4D5A6AQ35172737-465E48ED-B68D-4F3F-9465-9D7FEE85AA5CQ35212934-3E2FA529-89C7-4C21-A619-5E48D11E09BDQ35282687-9F9CAFF4-6E30-4245-843C-E8CDBA44E090Q35345339-DF41FE1C-7054-4356-946A-6749AB1306BCQ35573378-9093C55C-268C-4F55-A51C-520EA4B8B5AAQ35586297-CDEB94FF-CA2C-4E1E-A2F0-BCD55F2776E6Q35607862-4416BF45-326B-4862-9EC6-05E540CADD28Q35634575-7C3B3680-FF68-4949-9E49-A03C1E470FAF
P2860
Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group.
description
1992 nĆ® lÅ«n-bĆ»n
@nan
1992幓ć®č«ę
@ja
1992幓å¦ęÆęē«
@wuu
1992幓å¦ęÆęē«
@zh-cn
1992幓å¦ęÆęē«
@zh-hans
1992幓å¦ęÆęē«
@zh-my
1992幓å¦ęÆęē«
@zh-sg
1992幓åøč”ęē«
@yue
1992幓åøč”ęē«
@zh
1992幓åøč”ęē«
@zh-hant
name
Assessment of patient outcome ...... an Multicenter Research Group.
@en
Assessment of patient outcome ...... an Multicenter Research Group.
@nl
type
label
Assessment of patient outcome ...... an Multicenter Research Group.
@en
Assessment of patient outcome ...... an Multicenter Research Group.
@nl
prefLabel
Assessment of patient outcome ...... an Multicenter Research Group.
@en
Assessment of patient outcome ...... an Multicenter Research Group.
@nl
P921
P1476
Assessment of patient outcome ...... an Multicenter Research Group.
@en
P2093
P304
P356
10.1016/0002-8703(92)90986-6
P407
P577
1992-10-01T00:00:00Z